Cargando…
Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element
Androgen receptor (AR) action is a hallmark of prostate cancer (PCa) with androgen deprivation being standard therapy. Yet, resistance arises and aberrant AR signaling promotes disease. We sought compounds that inhibited genes driving cancer but not normal growth and hypothesized that genes with con...
Autores principales: | Kregel, Steven, Bagamasbad, Pia, He, Shihan, LaPensee, Elizabeth, Raji, Yemi, Brogley, Michele, Chinnaiyan, Arul, Cieslik, Marcin, Robins, Diane M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229860/ https://www.ncbi.nlm.nih.gov/pubmed/32198885 http://dx.doi.org/10.1093/nar/gkaa178 |
Ejemplares similares
-
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells—identification of a novel androgen response element
por: Lanzino, Marilena, et al.
Publicado: (2010) -
A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression
por: Jin, Feng, et al.
Publicado: (2009) -
Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo
por: Sahu, Biswajyoti, et al.
Publicado: (2014) -
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
por: Decker, Keith F., et al.
Publicado: (2012) -
Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome
por: Malinen, Marjo, et al.
Publicado: (2017)